Objective　This　study　aimed　to　identify　the　incidence,　risk　factors,　and　outcomes　of　permanent　pacemaker　(PPM)　implantation　after　transcatheter　aortic　valve　implantation　(TAVI)　procedures.　Methods　A　retrospective　analysis　was　conducted　on　70　patients　who　underwent　TAVI　at　the　Department　of　Cardiology,　Fujian　Provincial　Hospital,　from　January　2018　to　March　2022.　Based　on　whether　a　new　PPM　was　implanted　after　TAVI,　all　patients　were　divided　into　two　groups:　NEW　PPM　and　NO　PPM.　Baseline　characteristics　and　clinical　data　were　compared　between　the　two　groups.　Univariate　analysis　was　used　to　analyze　different　variables　between　the　two　groups.　A　binary　logistic　regression　analysis　was　used　to　evaluate　independent　correlates　for　PPM　implantation　after　TAVI.　Results　The　mean　age　of　the　70　patients　was　73.1　+/-　8.8　years.　The　incidence　of　PPM　implantation　was　17.1%.　Patients　with　diabetes　and　chronic　kidney　disease　were　more　likely　to　require　PPM　(50%　vs.　20.7%,　p　=　0.042,　25%　vs.　5.2%,　p　=　0.042).　Our　study　did　not　identify　any　significant　differences　in　the　incidence　of　electrocardiographic　conduction　disturbances　except　for　the　previous　right　bundle　branch　block　(RBBB)　(NO　PPM　6.9%　vs.　NEW　PPM　33.3%,　p　＜　0.05).　We　found　that　prosthesis　size,　implantation　depth,　procedural　duration,　and　length　of　hospital　and　intensive　care　unit　(ICU)　stays　were　comparable　between　the　two　groups.　The　leading　independent　predictors　of　PPM　implantation　were　previous　RBBB　(odds　ratio　10.129,　p　=　0.034).　Conclusion　The　previous　RBBB　was　the　leading　independent　predictor　of　PPM　implantation.　New　PPM　was　not　associated　with　significantly　new-onset　left　BBB,　extended　post-procedure　hospitalization,　ICU　stay,　or　procedural　duration.